-
IMPORTANT CONSIDERATIONS IN THE SELECTION OF AI TOOLS TO SUPPORT HEALTH ECONOMIC MODEL REPLICATION
Aug 11, 2026, 17:16 PM -
ESTABLISHING THE VALUE OF HOSPITAL ELECTRONIC MEDICAL RECORD DATA IN THE HEALTH TECHNOLOGY ASSESSMENT AND REASSESSMENT PROCESS FOR ONCOLOGY: HEPATOCELLULAR CARCINOMA IN THE CHANG GUNG RESEARCH DATABASE AS A CASE STUDY
Aug 11, 2026, 17:16 PM -
ORGANIZATIONAL AND ECONOMIC IMPACT OF INTRODUCING REZAFUNGIN FOR INVASIVE CANDIDIASIS IN NON-NEUTROPENIC ADULTS: COMPARISON WITH CASPOFUNGIN
Aug 11, 2026, 17:16 PM -
NICE SEVERITY MODIFIER LEVELS AND CORRESPONDING REIMBURSEMENT PATHWAYS FOR ANTICANCER THERAPIES IN SOUTH KOREA: A DESCRIPTIVE ANALYSIS
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF A FIXED-DOSE INTRANASAL KETAMINE AND SUFENTANIL COMBINATION FOR PEDIATRIC ACUTE PAIN IN SWEDEN
Aug 11, 2026, 17:16 PM -
COMMUNITY-BASED VERSUS FACILITY-BASED DIRECTLY OBSERVED THERAPY FOR MULTIDRUG-RESISTANT TUBERCULOSIS IN UGANDA: A COST-UTILITY ANALYSIS
Aug 11, 2026, 17:16 PM -
STREAMLINED HTA IN THE UK: A COMPARATIVE ANALYSIS OF NICE'S PROPORTIONATE APPROACH AND SMC'S ABBREVIATED SUBMISSION PATHWAY
Aug 11, 2026, 17:16 PM -
WHOSE OUTCOMES? PATIENT INVOLVEMENT AND PATIENT-RELEVANT ENDPOINTS IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
ESTIMATING THE HEALTH AND ECONOMIC BURDEN OF SOCIOECONOMIC INEQUALITIES IN BREAST CANCER SCREENING: AN INDIVIDUAL-LEVEL MICROSIMULATION STUDY
Aug 11, 2026, 17:16 PM -
WEIGHT LOSS EFFECTIVENESS OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1RAS) WHEN USED WITH AND WITHOUT LIFESTYLE MODIFICATIONS: A RETROSPECTIVE REAL-WORLD STUDY
Aug 11, 2026, 17:16 PM -
A FRAMEWORK FOR EVALUATING THE ROBUSTNESS OF EXTERNAL CONTROL ARMS IN OVARIAN CANCER VIA GENERATIVE SYNTHETIC SIMULATION
Aug 11, 2026, 17:16 PM -
EARLY ECONOMIC EVALUATION OF A NOVEL ORTHOTIC CARE PATHWAY FOR HAND OSTEOARTHRITIS. A SCENARIO AND THRESHOLD ANALYSIS FROM AN NHS PERSPECTIVE
Aug 11, 2026, 17:16 PM -
QUANTITATIVE INVESTIGATION OF BACKGROUND FACTORS OF CYBERCHONDRIA IN A YOUNG ADULT SAMPLE
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS OF NON-NAïVE PATIENTS INITIATING OCRELIZUMAB VERSUS MODERATE-EFFICACY TREATMENTS FOR MULTIPLE SCLEROSIS: 2-YEAR REAL-WORLD EVIDENCE FROM THE FRENCH OLIDIA STUDY
Aug 11, 2026, 17:16 PM -
STRATEGIC LAUNCH SEQUENCING UNDER MFN - REASSESSING MARKET PRIORITIZATION BEYOND TRADITIONAL PRIORITY MARKETS
Aug 11, 2026, 17:16 PM -
WILLINGNESS TO PAY FOR HEALTH INSURANCE: A SYSTEMATIC REVIEW OF CONTINGENT VALUATION STUDIES IN UPPER-MIDDLE- AND HIGH-INCOME COUNTRIES IN AFRICA AND EURASIA
Aug 11, 2026, 17:16 PM -
COMPARATIVE ANALYSIS OF MEDICAL COSTS AND HEALTHCARE RESOURCE UTILIZATION (HCRU) BETWEEN INTRAVENOUS (IV) AND SUBCUTANEOUS (SC) FIXED-DOSE COMBINATION OF PERTUZUMAB AND TRASTUZUMAB IN BRAZILIAN PRIVATE ONCOLOGY PATIENTS: A RETROSPECTIVE REAL-WORLD...
Aug 11, 2026, 17:16 PM -
FROM TRIAL ENDPOINT TO REAL-WORLD REGISTRY: THE FATE OF PROS IN AIFA MONITORING
Aug 11, 2026, 17:16 PM -
A SYSTEMATIC LITERATURE REVIEW (SLR) AND INDIRECT TREATMENT COMPARISON (ITC) FEASIBILITY ASSESSMENT OF THE COMPARATIVE EFFICACY OF TREATMENTS IN HER2+, RAS WILD-TYPE (WT), METASTATIC COLORECTAL CANCER (MCRC)
Aug 11, 2026, 17:16 PM -
BEYOND CONTAMINATED COMPARATORS: VALIDATING A G-COMPUTATION FRAMEWORK FOR TREATMENT SWITCHING IN ONCOLOGY NMAS
Aug 11, 2026, 17:16 PM
